tirzepatide/niacinamide brand name Tirzepatide is the dual-action one. Instead of working on a single hormone, it targets two — GLP-1 and GIP — which is why it tends to have a stronger effect on appetite We are pleased to announce

Because compounded semaglutide has not been tested in clinical trials for weight loss, its effectiveness is uncertain and could vary from one batch to another

Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors

Consistent dosing, comprehensive provider support, attention to non-scale victories, and lifestyle habits that align with your goals all contribute to successful long-term maintenance

This pacing allows the body to adapt without unnecessary disruption

This is especially beneficial for individuals with conditions like prediabetes or type 2 diabetes, where managing blood sugar is crucial for overall health